{"id":6191,"date":"2021-02-24T15:33:31","date_gmt":"2021-02-24T15:33:31","guid":{"rendered":"https:\/\/www.healthinnovationnenc.org.uk\/?page_id=6191"},"modified":"2023-08-14T14:50:37","modified_gmt":"2023-08-14T13:50:37","slug":"clinical-guidance","status":"publish","type":"page","link":"https:\/\/healthinnovationnenc.org.uk\/what-we-do\/driving-digital-transformation\/the-tees-remote-ecg-pathway\/clinical-guidance\/","title":{"rendered":"Clinical Guidance"},"content":{"rendered":"
In this section, you will find examples of clinical guidance relating to the management and monitoring of patient\u2019s on anti-psychosis medication.<\/p>\n
<\/p>\n
This includes an overview from the National Institute for Health and Care Excellence (NICE)<\/strong><\/a><\/p>\n <\/p>\n Guidelines for the Management of QTc Prolongation in Adults Prescribed Antipsychotics<\/p>\n